Polyacrylamide-punicic acid conjugate-based micelles for flutamide delivery in PC3 cells of prostate cancer: synthesis, characterisation and cytotoxicity studies

IET Nanobiotechnology
Razieh Mirsafaei, Jaleh Varshosaz

Abstract

The aim of the present study was to synthesize a novel biopolymeric micelle based on punicic acid (PA) and polyacrylamide (PAM) for carrying chemotherapeutic drugs used in prostate cancer treatment. A polymer composite micelle was prepared by chemical conjugation between PAM and PA. The micelles were prepared by self-assembly via film casting followed by ultrasonication method. The successful production of PAMPA copolymeric micelles was confirmed using FTIR, 1H-NMR, and TEM. Then, flutamide was loaded in the designed nanomicelles and they were characterized. The cell cytotoxicity of the micelles was studied on PC3 cells of prostate cancer. The prepared nanomicelles showed the particle size of 88 nm, PDI of 0.246, zeta potential of -9 mV, drug loading efficiency of 94.5%, drug release of 85.6% until 10 hours in pH 7.4 and CMC of 74.13 μg/ml. The cell viability in blank nanocarriers was about 70% in PC3 cells at concentration of 25 μM. More significant cytotoxic effects were seen for flutamide loaded micelles at this concentration compared to the free drug. The results suggest that the PAMPA co-polymeric nanomicelles can be utilized as an effective carrier to enhance the cytotoxic effects of flutamide in prostate cancer.

References

Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·S Y KimY K Sung
Sep 2, 1999·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·M Jones, J Leroux
Jun 6, 2000·Advanced Drug Delivery Reviews·V S Trubetskoy
Jun 5, 2002·Nature Reviews. Cancer·Samuel R Denmeade, John T Isaacs
Mar 20, 2004·Science·Theresa M Allen, Pieter R Cullis
Apr 6, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·J SiepmannJ P Benoit
Sep 30, 2005·Proceedings of the National Academy of Sciences of the United States of America·Arshi MalikHasan Mukhtar
Dec 29, 2005·Journal of Medicinal Food·M A Louis JeuneJ Brown
Jul 5, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Allan J PantuckArie Belldegrun
Aug 4, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Zerrin SezginTamer Baykara
Dec 13, 2006·Journal of Ethnopharmacology·Ephraim P Lansky, Robert A Newman
Jun 15, 2007·Toxicologic Pathology·Susan Elmore
Jul 7, 2007·The AAPS Journal·Vladimir P Torchilin
Jul 17, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Y TianKam C Tam
Mar 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kwangjae ChoDong M Shin
Jul 26, 2008·Nature Nanotechnology·Dan PeerRobert Langer
Apr 21, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Andrew S Mikhail, Christine Allen
Jul 30, 2009·Expert Opinion on Drug Delivery·Marian E Gindy, Robert K Prud'homme
Aug 4, 2009·Expert Opinion on Drug Delivery·Xiuli Hu, Xiabin Jing
Nov 21, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Geneviève GaucherJean-Christophe Leroux
Feb 16, 2010·Nutrition and Cancer·Vaqar Mustafa AdhamiHasan Mukhtar
Aug 24, 2010·Drug Discovery Today·Ranjita MisraSanjeeb K Sahoo
Nov 12, 2010·Journal of Agricultural and Food Chemistry·Jihane Gasmi, J Thomas Sanderson
Jun 21, 2011·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Oct 16, 2012·Translational Oncology·Lei WangManuela Martins-Green
Feb 7, 2018·Materials Science & Engineering. C, Materials for Biological Applications·Kalyani Prusty, Sarat K Swain
Feb 8, 2018·Frontiers in Pharmacology·Peilan QiShiyong Song
Jun 30, 2018·Chemical Reviews·Horacio CabralKazunori Kataoka

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.